MedTrace Logo

Assessment of the Effect of Botulinum Toxin in Extensor Digitorum Brevis Via Strain Gauge and Nerve Conduction Studies

NCT00822523 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2018-09-05

Study results available
· View outcomes & findings →

Summary

The purpose of this feasibility study is to determine if temporary weakness of a small foot muscle caused by local injection of botulinum toxin into that muscle can be measured with a strain gauge in addition to the previously known valid measurements via nerve conduction studies and surface electromyogram.

Conditions

  • Muscle Strength
  • Botulinum Toxins, Type A

Interventions

DRUG

Botulinum Toxin, Type A

20 units, single dose, intramuscular in right EDB muscle

DRUG

Botulinum Toxin, Type A

2 units, single dose, intramuscular to right EDB muscle

DRUG

Saline

Single Dose, Intramuscular into right EDB muscle

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Gordon W Peterson, MD · Loma Linda University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
54 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-03-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00822523 on ClinicalTrials.gov